Q2 2022 Holdings
Filed 2022-08-15 | 20 holdings | $106.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $67.7M | 2,669,974 | 63.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $20.5M | 761,398 | 19.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.5M | 933,743 | 8.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.5M | 178,500 | 7.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.2M | 260,000 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $116.8K | 2,583,059 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $44.6K | 2,551,703 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $26.3K | 330,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $23.1K | 2,758,069 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $18.1K | 243,400 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $10.1K | 763,456 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $7.8K | 575,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $4.7K | 321,641 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $4.4K | 632,745 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.2K | 152,249 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $2.3K | 199,876 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.3K | 579,061 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $2.3K | 80,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $1.1K | 1,000,000 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $325 | 122,800 | 0.0% |